Biofrontera Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.016 million compared to USD 0.015 million a year ago. Revenue was USD 4.46 million compared to USD 5.86 million a year ago. Net loss was USD 0.85 million compared to USD 3.66 million a year ago. Basic loss per share from continuing operations was USD 1 compared to USD 9.2 a year ago. Diluted loss per share from continuing operations was USD 1 compared to USD 9.2 a year ago.
For the six months, sales was USD 0.031 million compared to USD 0.028 million a year ago. Revenue was USD 14.21 million compared to USD 10.6 million a year ago. Net income was USD 4.71 million compared to net loss of USD 7.2 million a year ago. Basic earnings per share from continuing operations was USD 5.2 compared to basic loss per share from continuing operations of USD 18 a year ago. Diluted earnings per share from continuing operations was USD 5.2 compared to diluted loss per share from continuing operations of USD 18 a year ago.